FERRARI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.227
NA - Nord America 16.872
AS - Asia 3.091
SA - Sud America 155
AF - Africa 52
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 28
Totale 39.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.707
IT - Italia 11.581
GB - Regno Unito 3.367
CN - Cina 1.130
SE - Svezia 837
SG - Singapore 832
DE - Germania 695
UA - Ucraina 608
FR - Francia 425
HK - Hong Kong 402
FI - Finlandia 354
NL - Olanda 349
TR - Turchia 322
RU - Federazione Russa 249
BG - Bulgaria 222
CH - Svizzera 181
CA - Canada 107
BR - Brasile 73
IE - Irlanda 70
IN - India 69
KR - Corea 61
ID - Indonesia 59
IR - Iran 51
ES - Italia 47
BE - Belgio 41
MX - Messico 36
AU - Australia 35
CZ - Repubblica Ceca 32
JP - Giappone 28
GR - Grecia 25
EU - Europa 24
VN - Vietnam 23
TW - Taiwan 22
CO - Colombia 21
PE - Perù 21
DK - Danimarca 19
EG - Egitto 19
HU - Ungheria 17
RO - Romania 17
EC - Ecuador 16
MY - Malesia 15
SK - Slovacchia (Repubblica Slovacca) 15
CL - Cile 14
LT - Lituania 14
PH - Filippine 14
PT - Portogallo 13
ZA - Sudafrica 13
PL - Polonia 12
CR - Costa Rica 11
SA - Arabia Saudita 10
NO - Norvegia 9
PK - Pakistan 9
MN - Mongolia 8
IL - Israele 6
AR - Argentina 5
AT - Austria 5
BO - Bolivia 5
MA - Marocco 5
IQ - Iraq 4
KE - Kenya 4
LU - Lussemburgo 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
RS - Serbia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
BZ - Belize 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HR - Croazia 3
PR - Porto Rico 3
SC - Seychelles 3
SI - Slovenia 3
TN - Tunisia 3
AM - Armenia 2
BH - Bahrain 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
UZ - Uzbekistan 2
A1 - Anonimo 1
BD - Bangladesh 1
KW - Kuwait 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
PS - Palestinian Territory 1
SM - San Marino 1
SY - Repubblica araba siriana 1
Totale 39.464
Salva come PNG Salva come JPEG
Città #
Southend 2.835
Santa Clara 1.896
Fairfield 1.875
Woodbridge 1.380
Milan 1.320
Jacksonville 1.280
Chandler 1.146
Ashburn 1.101
Houston 933
Ann Arbor 727
Dearborn 708
Seattle 694
Wilmington 688
Singapore 649
Cambridge 645
Nyköping 476
Rome 439
Hong Kong 396
Beijing 364
Turin 351
Princeton 255
Sofia 216
Modena 213
Eugene 205
Izmir 199
Genoa 189
Brescia 180
San Diego 173
Florence 170
Helsinki 164
Redwood City 144
Bologna 101
Moscow 92
Monza 78
Verona 78
Falls Church 77
Bergamo 72
Des Moines 71
Parma 68
Naples 64
Dublin 63
Padova 60
Shanghai 57
Norwalk 56
Jakarta 54
Perugia 54
Boardman 52
London 52
New York 52
Fremont 45
Palermo 45
Nanjing 44
Bremen 41
Frankfurt am Main 39
Pescara 39
Catania 37
Torino 37
Ottawa 33
Tulare 33
Busto Arsizio 32
Kunming 32
Trieste 31
Bari 30
Brussels 30
Hefei 30
Lucca 30
Paris 30
Guangzhou 28
Toronto 28
Dallas 24
Venice 24
Genova 23
Ancona 22
Como 22
Zurich 22
Livorno 21
Los Angeles 20
Messina 20
Mountain View 20
Piacenza 20
San Mateo 20
Trento 20
Dong Ket 19
Munich 19
Nanchang 19
Treviso 19
La Spezia 18
Novara 18
Reggio Emilia 18
Siena 18
Washington 18
Hounslow 17
Udine 17
Cagliari 16
Chieti 16
Indiana 16
Lausanne 16
Pisa 16
Verdellino 16
Jinan 15
Totale 24.495
Salva come PNG Salva come JPEG
Nome #
Monitoraggio dei pazienti con uso/abuso alcolico mediante la determinazione dell'Etil glucuronide (EtG) nel capello 8.035
Krokodil: The drug that kills 2.253
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 1.341
Allopregnanolone serum levels in female migraineurs 646
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 566
Monitoring of adherence to headache treatments by means of hair analysis 315
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS 307
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 295
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 294
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors 282
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 256
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone 249
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients 245
Effective prophylactic treatments of migraine lower plasma glutamate levels 239
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 236
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study 235
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 234
Farmacologia e Tossicologia 232
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 232
Methadone - metabolism, pharmacokinetics and interactions 231
Adverse reactions related to drugs for headache treatment: clinical impact 229
Paracetamol: new vistas of an old drug 218
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients 208
Analgesic drug taking: Beliefs and behavior among headache patients 208
Clinical pharmacology of topiramate in migraine prevention 207
Polypharmacy Among Headache Patients: A Cross-Sectional Study 207
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 204
Past, present, and future prospects of medication-overuse headache classification 201
Basal cutaneous pain threshold in headache patients 201
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 201
Effect of sumatriptan in different models of pain in rats 201
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 199
Similarities and differences between chronic migraine and episodic migraine 199
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 198
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments 192
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. 190
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 187
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report 186
How children and parents evaluate the headache centre's intervention 184
Focus on headache as an adverse reaction to drugs 182
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ) 181
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 179
Pharmacoepidemiology of triptans in a headache centre 179
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments 178
Headache: one of the most common and troublesome adverse reactions to drugs. 177
Paracetamol revisited 177
Tramadol Abuse in a Binge Pattern in a Young Depressed Woman 175
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis 175
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 174
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 174
Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy 173
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal from the overused combination of indomethacin, Prochlorperazine and caffeine 173
Italian guidelines for primary headaches: 2012 revised version. 172
Glutamate receptor antagonists with the potential for migraine treatment 170
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 169
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 167
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients 164
Abuse of tramadol in a binge pattern in a young woman 163
Analgesic abuse in chronic headache sufferers 162
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 162
Proteomic serum profile in menstrual-related and post menopause migraine 162
Storia della Sindrome di Neri Barrè 160
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 158
Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente 158
Trattamento farmacologico integrato per la terapia delle tossicodipendenze 158
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage 157
Hypertension and migraine comorbidity: Prevalence and risk of cerebrovascular events: Evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) 157
Plasma glutathione level in chronic headache drug abuser patients 155
Zopiclone and prazepam abuse in a chronic migraine patient 155
Zopiclone and prazepam dependance: role of hair analysis for the monitoring of treatment in a migraine patient 154
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 153
Clinical considerations preliminary to application of the Italian Society for the Study of Headache’s guidelines regarding migraine prophylactic treatment 152
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 149
Sucrose intake: Increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73 144
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 143
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 143
Adolescenza, sostanze stupefacenti, riti di passaggio 141
Different effect of sumatriptan in models of thermal, chemical or cephalalgic pain, in rats 139
Hair testing as a marker of adherence to headache treatments 138
Evaluation of the analgesic effect of nabilone versus acetaminophen plus caffeine in an inflammatory pain model (tail flik test) in rats. 137
Un caso complesso di medication-overuse headache e dipendenza da ipnoinducenti: ruolo dell’analisi del capello per il monitoraggio del trattamento. 137
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 136
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal of the overused combination of indomethacin, prochlorperazine, and caffeine 135
Trattamento farmacologico del dolore postoperatorio 135
Accanimento terapeutico o riduzione del danno 134
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 134
Pharmacological treatment of drug dependence in daily chronic headache sufferers 133
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 133
Chronic treatment with naltrexone and hepatic functions in heroin addicts 131
Prophylaxis of food-induced migraine with cromolyn sodium: efficacy of short and long-term use 131
Effects of long-term treatment with naltrexone on hepatic enzyme activity. 129
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 129
Folate, vitamin B12, and serum homocysteine levels in patients with chronic migraine and medication-overuse headache 127
Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial 126
INFLUENCE OF FLUNARIZINE ON THE ALTERED ELECTRONYSTAGMOGRAPHIC (ENG) RECORDINGS IN MIGRAINE 126
Headache as an Adverse Reaction to Medication 124
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 124
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 122
Proteomic serum profile of female migraineurs 122
Azioni, interazioni, controindicazioni, tossicità dei farmaci utilizzati nella terapia dell'emicrania 121
Totale 29.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 127.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.124 0 0 0 0 0 0 1.002 547 555 265 457 298
2020/20215.271 575 274 479 322 574 297 435 716 225 673 448 253
2021/20224.493 169 519 430 465 191 223 256 296 449 315 568 612
2022/20235.226 494 438 281 409 526 604 248 531 682 252 426 335
2023/20246.492 276 362 371 578 746 468 719 722 389 501 685 675
2024/20256.138 679 491 494 937 1.951 1.498 88 0 0 0 0 0
Totale 39.725